AtriCure, Inc.·4

May 20, 9:25 AM ET

GROVES REGINA E 4

4 · AtriCure, Inc. · Filed May 20, 2026

Research Summary

AI-generated summary of this filing

Updated

AtriCure (ATRC) Director Regina Groves Receives Restricted Stock Award

What Happened
Regina E. Groves, a director of AtriCure, Inc. (ATRC), was granted 6,144 restricted shares on May 18, 2026. The shares were awarded at $0.00 per share (total acquisition value $0) under AtriCure’s 2023 Stock Incentive Plan. This was an award/grant (not a purchase or sale).

Key Details

  • Transaction date: 2026-05-18; Filing date: 2026-05-20 (filed within the typical two-business-day Form 4 window).
  • Transaction type: Award/Grant (code A). Price per share: $0.00. Total reported value: $0.
  • Shares granted: 6,144 restricted common shares.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote: The shares were issued pursuant to a Restricted Stock Award under the 2023 Stock Incentive Plan and will vest on the one-year anniversary of the grant date (per filing footnote).

Context
Restricted stock awards are standard compensation for directors and typically vest over time; they represent a deferred equity grant rather than a market purchase or sale. A $0 grant price reflects a compensatory award, which does not itself indicate immediate market sentiment.

Insider Transaction Report

Form 4
Period: 2026-05-18
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-18+6,14439,859 total
Footnotes (1)
  • [F1]The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.
Signature
/s/ Allison Walker as Attorney-in-fact for Regina E. Groves|2026-05-20

Documents

1 file
  • 4
    wk-form4_1779283525.xmlPrimary

    FORM 4